Fig. 2.
Plasma levels of serum total and free cortisol and cortisol binding globulin. Plasma levels of (A) serum total cortisol, (B) cortisol binding globulin, (C) serum free cortisol and (D) serum total cortisol/serum free cortisol ratio in patients with different stages of ACLD.
Patients stratified by EASL stages. Levels of significance of group comparisons determined by the Kruskal–Wallis test: (A) p = 0.091, (B) p <0.001, (C) p = 0.474, and (D) p = 0.002. The median and interquartile range for every group is shown.
